You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for norethindrone acetate


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for norethindrone acetate

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial N6127_SIGMA ⤷  Start Trial
TCI (Tokyo Chemical Industry) ⤷  Start Trial N0450 ⤷  Start Trial
Molport ⤷  Start Trial MolPort-003-901-032 ⤷  Start Trial
TimTec ⤷  Start Trial ST075199 ⤷  Start Trial
Amadis Chemical ⤷  Start Trial A828876 ⤷  Start Trial
AKos Consulting & Solutions ⤷  Start Trial AKOS016010517 ⤷  Start Trial
Finetech Industry Limited ⤷  Start Trial FT-0631227 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Norethindrone Acetate

Last updated: February 20, 2026

Norethindrone acetate (NTA) is a progestin used in hormonal contraceptive formulations and hormone replacement therapy. The API supply chain involves multiple regions, primarily China, India, and Europe, which host manufacturers producing bulk NTA for global distribution.

Major API Manufacturers and Suppliers

Supplier Name Country Estimated Capacity Certification Notable Features
Hainan Hainice Pharmaceutical China ~50 metric tons/year GMP, ISO 9001 Offers NTA with consistent quality for generic markets
Jiangsu Yabang Pharmaceutical China ~40 metric tons/year GMP Focuses on high purity NTA for U.S. and European markets
Synthon Biopharmaceuticals India 30-45 metric tons/year WHO-GMP, USFDA Supplier to global generics manufacturers
Gedeon Richter Hungary 20-25 metric tons/year EUGMP Known for high-quality APIs and supply stability
Zhaojia Pharmaceutical China Approx. 35 metric tons/year GMP Competitive pricing, large capacity

Key Production Countries

  • China: Dominates the market with numerous API producers, offering extensive capacity and competitive pricing.
  • India: Supplies APIs primarily to North American and European companies, with stringent GMP standards.
  • Europe: Hosts several high-quality API manufacturers with an emphasis on compliance and quality assurance.

Supply Chain Trends and Market Dynamics

Concentration and Expansion

The NTA API market is largely concentrated among Chinese and Indian manufacturers. Increasing capacity in these regions aims to meet rising demand for generics. Recent expansions reflect investments in cGMP facility upgrades and quality systems compliance.

Regulatory Impact

Manufacturers with FDA, EMA, and WHO-GMP certifications dominate exports to regulated markets. Stringent quality standards influence sourcing decisions, favoring suppliers with mature regulatory dossiers.

Price Trends

API prices for NTA have decreased over the past three years due to competition and increased capacity. The average price range for bulk NTA is $200-$300 per kilogram (2023 data), with Chinese supply slightly lower on average than Indian sources.

Sourcing Considerations

Factor Description
Quality Assurance Certification (GMP, WHO-GMP, USFDA, EUGMP) demands are critical for API acceptance.
Lead Time Longer lead times may result from customs clearance, certification, and production scheduling.
Price Market prices fluctuate based on capacity, raw material costs, and geopolitical factors.
Reliability Stability of supply chains depends on manufacturer diversification and inventory levels.

Regulatory and Certification Standards

Certification Scope Significance
GMP Good Manufacturing Practice Ensures manufacturing quality and compliance with regulatory standards.
ISO 9001 Quality management system Validates quality assurance processes.
USFDA, EMA, EUGMP Regional certification standards Required for APIs used in regulated markets.

Manufacturers with multiple certifications pose lower regulatory risk for proprietary formulations.

Global Market Access and Export Dynamics

Chinese APIs dominate exports to North America and Europe due to capacity and pricing. India remains significant in supplying APIs to emerging markets and cost-sensitive regions. European manufacturers mainly supply higher-cost, high-quality APIs with advanced regulatory approval.

Future Supply Trends

  • Capacity expansions in China and India aim to balance current supply constraints.
  • Potential barriers include stricter environmental and safety regulations.
  • Increasing quality standards may limit some manufacturers’ export capabilities.

Key Takeaways

  • China leads in capacity and pricing for bulk NTA APIs.
  • Indian manufacturers provide competitive pricing with approved certifications.
  • European suppliers focus on high-quality APIs with advanced compliance standards.
  • Market prices for NTA API have trended downward, influenced by capacity growth.
  • Regulatory certification is critical for supply to developed markets, influencing supplier choice.

FAQs

Q1: Which countries dominate the supply of norethindrone acetate API?
A1: China and India dominate the supply, with European manufacturers also supplying high-quality APIs.

Q2: What certifications are essential for APIs in regulated markets?
A2: GMP, WHO-GMP, USFDA, and EUGMP are essential for APIs used in North America, Europe, and other regulated regions.

Q3: What factors influence the price of bulk NTA API?
A3: Capacity, raw material costs, certification levels, and geopolitical stability influence API pricing.

Q4: How does capacity expansion impact the NTA API market?
A4: It increases supply, potentially reducing prices and improving market stability but may lead to oversupply if demand does not keep pace.

Q5: What are the primary considerations when sourcing NTA API?
A5: Quality certifications, supply reliability, pricing, and lead times are key considerations.


References

[1] GlobalData. (2023). API Market Analysis.
[2] IQVIA. (2023). Pharmaceutical Manufacturing Capacities.
[3] U.S. Food and Drug Administration. (2023). API Regulatory Requirements.
[4] European Medicines Agency. (2023). Good Manufacturing Practice Standards.
[5] Industry reports. (2022). Norethindrone Acetate Market Trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.